Sikander Ailawadhi, Mayo Clinic, Jacksonville, US, talks to the MM Hub at ASCO 2019, about how racial disparities influence the outcomes of patients with multiple myeloma. Sikander Ailawadhi discusses the growing complexity in defining racial subgroups, and highlights the need for an acceptance across institutions that the care we deliver is not uniform and this is leading to differences in patient outcomes. He highlights the next step will be to determine whether these underlying factors are the same across all subgroups, or are unique, and then to determine the best route to overcome them. To overcome these issues will involve opening a wider discussion, which this session at ASCO has taken great strides towards achieving.
The European School of Haematology (ESH) is a not for profit institution for the dissemination of information and lifelong learning founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in haematology and related disciplines at the European level. ESH Conferences present state-of-the-art science and insight into new developments in the fields of basic, clinical and therapeutic research in Haematology